CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors

Key Points Increased immune suppressors and PD-1 abrogates effector responses in CML patients at diagnosis. Enhanced net effector immune responses and decreased PD-1 and immune suppressors may promote sustained deep molecular response in CML.